Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EDGARDO A FAYLONA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1083611362
CMS profile
185485
Location
LAS VEGAS, NV

General Payments · PY2018–2024

$56,522.26

  • Reported across 628 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$11,341.83

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $8,185.00 4
Food and Beverage $2,210.93 29
Travel and Lodging $655.93 2
Education $289.97 3

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $11,315.43 195
PY2019 $9,597.58 195
PY2020 $7,177.03 42
PY2021 $4,188.41 39
PY2022 $4,445.29 81
PY2023 $8,456.69 38
PY2024 $11,341.83 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $124.97 05/22/2024 Food and Beverage Undisputed 01/23/2026 1139378936 CMS
AstraZeneca Pharmaceuticals LP $1,675.00 12/16/2024 Consulting Fee Undisputed 01/23/2026 1104520154 CMS
Aveo Pharmaceuticals, Inc. $99.99 05/01/2024 Education Undisputed 01/23/2026 1143476899 CMS
Aveo Pharmaceuticals, Inc. $139.93 10/09/2024 Food and Beverage Undisputed 01/23/2026 1143476906 CMS
BeiGene USA, Inc. $1,925.00 05/17/2024 Consulting Fee Undisputed 01/23/2026 1120853757 CMS
E.R. Squibb & Sons, L.L.C. $149.98 06/20/2024 Food and Beverage Undisputed 01/23/2026 1101850125 CMS
EMD Serono, Inc. $77.33 04/10/2024 Food and Beverage Undisputed 01/23/2026 1120246077 CMS
EMD Serono, Inc. $88.15 11/06/2024 Food and Beverage Undisputed 01/23/2026 1120274658 CMS
GENZYME CORPORATION $40.07 03/21/2024 Food and Beverage Undisputed 01/23/2026 1139619537 CMS
Gilead Sciences, Inc. $25.13 04/04/2024 Food and Beverage Undisputed 01/23/2026 1133804483 CMS
Gilead Sciences, Inc. $148.76 10/04/2024 Food and Beverage Undisputed 01/23/2026 1133804485 CMS
Gilead Sciences, Inc. $321.96 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1133866616 CMS
Gilead Sciences, Inc. $333.97 10/04/2024 Travel and Lodging Undisputed 01/23/2026 1133866618 CMS
Gilead Sciences, Inc. $48.91 10/05/2024 Food and Beverage Undisputed 01/23/2026 1133804487 CMS
Gilead Sciences, Inc. $50.05 10/05/2024 Food and Beverage Undisputed 01/23/2026 1133804489 CMS
Gilead Sciences, Inc. $60.00 10/05/2024 Food and Beverage Undisputed 01/23/2026 1133804491 CMS
Gilead Sciences, Inc. $2,860.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1133599439 CMS
Janssen Biotech, Inc. $99.99 07/01/2024 Education Undisputed 01/23/2026 1078396457 CMS
Lilly USA, LLC $109.44 10/10/2024 Food and Beverage Undisputed 01/23/2026 1136165196 CMS
Novartis Pharmaceuticals Corporation $31.01 05/03/2024 Food and Beverage Undisputed 01/23/2026 1086870177 CMS
Novartis Pharmaceuticals Corporation $32.28 08/16/2024 Food and Beverage Undisputed 01/23/2026 1086870187 CMS
Novartis Pharmaceuticals Corporation $61.54 11/14/2024 Food and Beverage Undisputed 01/23/2026 1086870193 CMS
Novo Nordisk Inc $16.92 10/30/2024 Food and Beverage Undisputed 01/23/2026 1097193752 CMS
Novocure Inc. $120.05 06/12/2024 Food and Beverage Undisputed 01/23/2026 1123335043 CMS
Regeneron Healthcare Solutions, Inc. $97.64 02/16/2024 Food and Beverage Undisputed 01/23/2026 1114046000 CMS
Regeneron Healthcare Solutions, Inc. $14.36 04/15/2024 Food and Beverage Undisputed 01/23/2026 1114046002 CMS
Regeneron Healthcare Solutions, Inc. $21.75 04/30/2024 Food and Beverage Undisputed 01/23/2026 1114046004 CMS
Regeneron Healthcare Solutions, Inc. $6.38 11/21/2024 Food and Beverage Undisputed 01/23/2026 1114046006 CMS
SOBI, INC $89.99 06/06/2024 Education Undisputed 01/23/2026 1141438555 CMS
SOBI, INC $118.08 07/15/2024 Food and Beverage Undisputed 01/23/2026 1141438485 CMS
SOBI, INC $55.87 08/14/2024 Food and Beverage Undisputed 01/23/2026 1141438641 CMS
SOBI, INC $1,725.00 08/22/2024 Consulting Fee Undisputed 01/23/2026 1141438705 CMS
SOBI, INC $154.05 09/05/2024 Food and Beverage Undisputed 01/23/2026 1141438971 CMS
SOBI, INC $75.00 10/17/2024 Food and Beverage Undisputed 01/23/2026 1141438731 CMS
Stemline Therapeutics Inc. $172.35 03/27/2024 Food and Beverage Undisputed 01/23/2026 1142959540 CMS
Stemline Therapeutics Inc. $24.46 06/20/2024 Food and Beverage Undisputed 01/23/2026 1142959542 CMS
Takeda Pharmaceuticals U.S.A., Inc. $121.81 02/29/2024 Food and Beverage Undisputed 01/23/2026 1144957371 CMS
ViiV Healthcare Company $24.66 09/05/2024 Food and Beverage Undisputed 01/23/2026 1112716342 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.